Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 4/20 | 0.42 |
| ▸ | BCL2 | P10415 | 1/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | MET | P08581 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24129479 | 0.82 | SLC6A4 (0.38) | ENPP1METUSP2PDE1B | |
| SCHEMBL2589386 | 0.75 | ENPP1 (0.53) | ENPP1USP2GAASMN1; SMN2MAPT | |
| SCHEMBL7096531 | 0.73 | ALDH1A1 (0.48) | AURKAGAAALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL2582203 | 0.72 | ENPP1 (0.51) | ENPP1GAAALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL19668727 | 0.72 | RAB9A (0.51) | ALDH1A1KDM4ESMN1; SMN2MAPTMAPK1 | |
| SCHEMBL10336647 | 0.69 | ENPP1 (0.47) | ENPP1GAAALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL19668746 | 0.67 | NPC1 (0.53) | GAAALDH1A1KDM4ESMN1; SMN2MAPT | |
| SCHEMBL24129195 | 0.65 | SLC6A2 (0.38) | ENPP1USP2ALDH1A1SMN1; SMN2PDE1B | |
| SCHEMBL4694580 | 0.64 | ENPP1 (0.53) | ENPP1GAAALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL3916291 | 0.64 | BCL2 (0.47) | BCL2BCL2L1PAX8ALDH1A1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040063729-A1 | Microbiocides | BAYER CROPSCIENCE K. K. (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1345940-A2 | TRIAZOLOPYRIMIDINES | Bayer CropScience K.K. (JP) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002051845-A2 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE K.K. (DE) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063729-A1 | Microbiocides | FPR1, MPO, FPR2 | ENPP1 929/4885BCL2 1656/4885BCL2L1 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.